PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Potato evolved from tomato 9 million years ago

2025-07-31
(Press-News.org) An international research team has uncovered that natural interbreeding in the wild between tomato plants and potato-like species from South America about 9 million years ago gave rise to the modern-day potato. 

In a study publishing in the Cell Press journal Cell, researchers suggest this ancient evolutionary event triggered the formation of the tuber, the enlarged underground structure that stores nutrients found in plants like potatoes, yams, and taros. 

“Our findings show how a hybridization event between species can spark the evolution of new traits, allowing even more species to emerge,” says corresponding author Sanwen Huang of the Chinese Academy of Agricultural Sciences, China. “We’ve finally solved the mystery of where potatoes came from.” 

As one of the world’s most important crops, the potato’s origin had long puzzled scientists. In appearance, modern potato plants are almost identical to three potato-like species from Chile called Etuberosum. But these plants do not carry tubers. Based on phylogenetic analysis, potato plants are more closely related to tomatoes. 

To solve this contradiction, the research team analyzed 450 genomes from cultivated potatoes and 56 of the wild potato species. 

“Wild potatoes are very difficult to sample, so this dataset represents the most comprehensive collection of wild potato genomic data ever analyzed,” says the paper’s first author Zhiyang Zhang of the Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences. 

They found that every potato species contained a stable, balanced mix of genetic material from both Etuberosum and tomato plants, suggesting that potatoes originated from an ancient hybridization between the two.  

While Etuberosum and tomatoes are distinct species, they shared a common ancestor about 14 million years ago. Even after diverging for about 5 million years, they were able to interbreed and gave rise to the earliest potato plants with tubers around 9 million years ago. 

The team also traced the origins of the potato’s key tuber-forming genes, which are a combination of genetic material from each parent. They found the SP6A gene, which acts like a master switch that tells the plant when to start making tubers, came from the tomato side of the family. Another important gene called IT1, which helps control growth of the underground stems that form tubers, came from the Etuberosum side. Without either piece, the hybrid offspring would be incapable of producing tubers. 

This evolutionary innovation coincided with the rapid uplift of the Andes mountains, a period when new ecological environments were emerging. With a tuber to store nutrients underground, early potatoes were able to quickly adapt to the changing environment, surviving harsh weather in the mountains. 

Tubers also allow potato plants to reproduce without seeds or pollination. They grow new plants by simply sprouting from buds on the tuber. This trait allowed them to rapidly expand and fill diverse ecological niches from mild grasslands to high and cold alpine meadows in Central and South America. 

“Evolving a tuber gave potatoes a huge advantage in harsh environments, fueling an explosion of new species and contributing to the rich diversity of potatoes we see and rely on today,” Huang said.  

### 

Cell, Zhang et al. “Ancient hybridization underlies tuberization and radiation of the potato lineage” https://www.cell.com/cell/fulltext/S0092-8674(25)00736-6 

Cell (@CellCellPress), the flagship journal of Cell Press, is a bimonthly journal that publishes findings of unusual significance in any area of experimental biology, including but not limited to cell biology, molecular biology, neuroscience, immunology, virology and microbiology, cancer, human genetics, systems biology, signaling, and disease mechanisms and therapeutics. Visit: http://www.cell.com/cell. To receive Cell Press media alerts, contact press@cell.com. 

END



ELSE PRESS RELEASES FROM THIS DATE:

MIT researchers show how the brain distinguishes 'things' from 'stuff'

2025-07-31
CAMBRIDGE, MA -- Imagine a ball bouncing down a flight of stairs. Now think about a cascade of water flowing down those same stairs. The ball and the water behave very differently, and it turns out that your brain has different regions for processing visual information about each type of physical matter. In a new study, MIT neuroscientists have identified parts of the brain’s visual cortex that respond preferentially when you look at “things” — that is, rigid or deformable objects like a bouncing ball. Other brain regions are more activated when looking at “stuff” — liquids or granular ...

Impact of the MISSION act on quality and outcomes of major cardiovascular procedures among veterans

2025-07-31
About The Study: The U.S. Congress enacted the Maintaining Internal Systems and Strengthening Integrated Outside Networks (MISSION) Act with the goal of improving veterans’ access to health care services. This study found that MISSION Act implementation was associated with substantial decreases in travel times among veterans who became geographically eligible for non-Veterans Affairs care. For these patients undergoing percutaneous coronary intervention or coronary artery bypass grafting, MISSION Act implementation was also associated with worsened 30-day major adverse cardiovascular events ...

Not all low-grade prostate cancers are low risk

2025-07-31
A new study reveals that some men who are diagnosed with “Grade Group one” (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell Medicine, University Hospitals Cleveland and Case Western University. The researchers conclude that relying on biopsy grade alone can lead to underestimating disease risk and misclassifying individuals who may benefit from definitive treatment with either surgery or radiation. Biopsies test only small areas of the prostate, so ...

GLP-1 RAs and risk of nonarteritic anterior ischemic optic neuropathy in older patients with diabetes

2025-07-31
About The Study: This study of Medicare enrollees age 65 or older with type 2 diabetes found an association between semaglutide use and an increased risk of nonarteritic anterior ischemic optic neuropathy. There was risk variation among the glucagon-like peptide-1 receptor agonists (GLP-1 RAs); semaglutide and liraglutide were associated with higher risks.  Corresponding Author: To contact the corresponding author, Kin Wah Fung, MD, email kfung@mail.nih.gov. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamaophthalmol.2025.2299) Editor’s ...

The clinical practice guideline update on adult sinusitis emphasizes patient education, shared decision-making, and evidence-based treatment options

2025-07-31
ALEXANDRIA, VA —The American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) published the Clinical Practice Guideline (CPG): Adult Sinusitis Update today in Otolaryngology–Head and Neck Surgery. The purpose of this multidisciplinary guideline is to identify quality improvement opportunities in managing adult sinusitis and to provide explicit and actionable guidance that can be implemented across all clinical practices. "With sinusitis affecting about one in eight adults in the United States each year, this CPG update empowers both patients and their healthcare providers with ...

Big data begins to crack the cold case of endometriosis

2025-07-31
Big Data Begins to Crack the Cold Case of Endometriosis Records from millions of patients at UC health centers found correlations between endometriosis, one of the most common diseases in women, and a bounty of other diseases.  Scientists at UCSF have found that endometriosis — a painful chronic disease affecting 10% of women that often goes undiagnosed — often occurs alongside conditions like cancer, Crohn's disease, and migraine. The research could improve how endometriosis is diagnosed and, ultimately, how it is treated; and it paints the sharpest portrait yet of a condition that is ...

This artificial sweetener could make cancer treatment less effective

2025-07-31
Sucralose is a popular sugar substitute for people who are cutting calories or managing blood sugar levels, but new research by the University of Pittsburgh and UPMC Hillman Cancer Center suggests that the artificial sweetener may not be the best choice for patients undergoing cancer immunotherapy. Publishing today in Cancer Discovery, a publication of the American Association for Cancer Research, the study found that patients with melanoma and non-small cell lung cancer who consumed high levels of sucralose had worse ...

Light-based listening: Researchers develop a low-cost visual microphone

2025-07-31
WASHINGTON — Researchers have created a microphone that listens with light instead of sound. Unlike traditional microphones, this visual microphone captures tiny vibrations on the surfaces of objects caused by sound waves and turns them into audible signals. “Our method simplifies and reduces the cost of using light to capture sound while also enabling applications in scenarios where traditional microphones are ineffective, such as conversing through a glass window,” said research team leader Xu-Ri Yao from Beijing ...

Immunoglobulin replacement therapy shows no reduction in serious infections for patients with CLL

2025-07-31
(WASHINGTON, July 31, 2025) — In patients with chronic lymphocytic leukemia (CLL), regular treatment with immunoglobulin replacement therapy was not associated with a reduced risk of serious infections requiring hospitalization, according to a study published in Blood Advances. “This is the first large, real-world study to follow patients with CLL who are regularly receiving immunoglobulin replacement,” said lead study author Sara Carrillo de Albornoz, health economist and a PhD candidate at Monash University in Australia. “Given its high cost and variable use in clinical ...

University of Colorado Anschutz Medical Campus awarded one of the largest clinical trial grants in campus history to lead trauma study

2025-07-31
AURORA, Colo. (July 31, 2025) – The University of Colorado Anschutz Medical Campus will lead a groundbreaking national clinical trial—supported by a $29 million grant from Octapharma—to evaluate whether early replacement of fibrinogen, a critical blood clotting mechanism in the body, can improve outcomes for trauma patients experiencing life-threatening bleeding. This investigator-initiated study is one of the largest clinical trial grants in campus history. The EFFECT Trial (Early ...

LAST 30 PRESS RELEASES:

Fat tissue around the heart may contribute to greater heart injury after a heart attack

Jeonbuk National University researcher proposes a proposing a two-stage decision-making framework of lithium governance in Latin America

Chromatin accessibility maps reveal how stem cells drive myelodysplastic progression

Cartilaginous cells regulate growth and blood vessel formation in bones

Plant hormone allows lifelong control of proteins in living animal for first time

Swedish freshwater bacteria give new insights into bacterial evolution

Global measures consistently underestimate food insecurity; one in five who suffer from hunger may go uncounted

Hidden patterns of isolation and segregation found in all American cities

FDA drug trials exclude a widening slice of Americans

Sea reptile’s tooth shows that mosasaurs could live in freshwater

Pure bred: New stem cell medium only has canine components

Largest study of its kind highlights benefits – and risks – of plant-based diets in children

Synergistic effects of single-crystal HfB2 nanorods: Simultaneous enhancement of mechanical properties and ablation resistance

Mysterious X-ray variability of the strongly magnetized neutron star NGC 7793 P13

The key to increasing patients’ advance care medical planning may be automatic patient outreach

Palaeontology: Ancient tooth suggests ocean predator could hunt in rivers

Polar bears may be adapting to survive warmer climates, says study

Canadian wildfire smoke worsened pediatric asthma in US Northeast: UVM study

New UBCO research challenges traditional teen suicide prevention models

Diversity language in US medical research agency grants declined 25% since 2024

Concern over growing use of AI chatbots to stave off loneliness

Biomedical authors often call a reference “recent” — even when it is decades old, analysis shows

The Lancet: New single dose oral treatment for gonorrhoea effectively combats drug-resistant infections, trial finds

Proton therapy shows survival benefit in Phase III trial for patients with head and neck cancers

Blood test reveals prognosis after cardiac arrest

UBCO study finds microdosing can temporarily improve mood, creativity

An ECOG-ACRIN imaging study solves a long-standing gap in metastatic breast cancer research and care: accurately measuring treatment response in patients with bone metastases

Cleveland Clinic presents final results of phase 1 clinical trial of preventive breast cancer vaccine study

Nationally renowned anesthesiology physician-scientist and clinical operations leader David Mintz, MD, PhD, named Chair of the Department of Anesthesiology at the UM School of Medicine

Clean water access improves child health in Mozambique, study shows

[Press-News.org] Potato evolved from tomato 9 million years ago